{
    "id": 28958,
    "fullName": "PTTG1 over exp",
    "impact": "none",
    "proteinEffect": "no effect",
    "geneVariantDescriptions": [
        {
            "description": "PTTG1 over exp indicates an over expression of the Pttg1 protein and/or mRNA. However, the mechanism causing the over expression is unspecified.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "non-specific",
    "gene": {
        "id": 9232,
        "geneSymbol": "PTTG1",
        "terms": [
            "PTTG1",
            "EAP1",
            "HPTTG",
            "PTTG",
            "TUTR1"
        ]
    },
    "variant": "over exp",
    "createDate": "11/24/2018",
    "updateDate": "11/24/2018",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 15232,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, ovarian cancer cell lines, overexpressing Pttg1, were resistant to Saracatinib (AZD0530) treatment, as demonstrated by decreased cell growth upon RNA silencing of Pttg1 (PMID: 27766744).",
            "molecularProfile": {
                "id": 30879,
                "profileName": "PTTG1 over exp"
            },
            "therapy": {
                "id": 912,
                "therapyName": "Saracatinib",
                "synonyms": null
            },
            "indication": {
                "id": 2394,
                "name": "ovarian cancer",
                "source": "DOID"
            },
            "responseType": "resistant",
            "references": [
                {
                    "id": 12946,
                    "pubMedId": 27766744,
                    "title": "PTTG1 Levels Are Predictive of Saracatinib Sensitivity in Ovarian Cancer Cell Lines.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/27766744"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 30879,
            "profileName": "PTTG1 over exp",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}